In a report released yesterday, Kristen Stewart from Barclays maintained a Hold rating on Conmed Corp (NASDAQ: CNMD), with a price target of $78. The company’s shares opened today at $73.29.
Stewart has an average return of 6.2% when recommending Conmed Corp.
According to TipRanks.com, Stewart is ranked #1629 out of 4887 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Conmed Corp with a $80.25 average price target.
See today’s analyst top recommended stocks >>
Based on Conmed Corp’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $8.72 million. In comparison, last year the company had a net profit of $7.2 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CONMED Corp. is a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific.
